证券记录 · 已归档季度
MRUS
Merus N.V. · Healthcare · Biotechnology
10被追踪持有人
—Δ持有人
6.42M持有股份
$379.66M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q4 2025 | 1 | -19 | 837 | $75,330 | — | −19 |
| Q3 2025 | 19 | +1 | 12.61M | $1.19B | +1 | — |
| Q2 2025 | 15 | +2 | 16.75M | $880.83M | +2 | — |
| Q1 2025 | 10 | -1 | 7.37M | $310.31M | — | −1 |
| Q4 2024 | 11 | 0 | 7.78M | $327.28M | — | — |
| Q3 2024 | 10 | 0 | 7.49M | $374.22M | — | — |
| Q2 2024 | 10 | — | 6.42M | $379.66M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 1.66M | — | $98.40M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.66M | — | $98.40M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.66M | — | $98.40M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.66M | — | $98.40M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.66M | — | $98.40M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.66M | — | $98.40M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.66M | — | $98.40M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 1.39M | — | $81.96M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 957.95K | — | $56.68M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 957.95K | — | $56.68M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 770.00K | — | $45.56M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 633.23K | — | $37.47M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 521.34K | — | $30.85M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 521.34K | — | $30.85M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 243.26K | — | $14.39M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 181.85K | — | $10.76M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 181.85K | — | $10.76M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 52.19K | — | $3.09M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 8.47K | — | $501,170 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 8.47K | — | $501,170 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据